Bioserenity
BioSerenity is medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients suffering from Chronic disease such as Epilepsy. The medical devices are composed of medical sensors, smart clothing, a smart phone app for Patient Reported Outcome, a web platform to perform data analysis through Medical Artificial Intelligence for detection of digital biomarkers. The company initially focused on Neurology a domain in which it reported contributing to the diagnosis of 30 000 patients per year. It now also operates in Sleep Disorders and Cardiology. BioSerenity reported it provides pharmaceutical companies with solutions for  companion diagnostics. Company history. BioSerenity was founded in 2014, by Pierre-Yves Frouin. The company was initially hosted in the ICM Institute (Institut du Cerveau et de la Moëlle épinière), in Paris, France. Fund Raising Acquisitions In 2019, BioSerenity announces the acquisition of the American Company SleepMed and working with over 200 Hospitals.